European hemp producers and manufacturers are getting renewed pleas to help fight the European Union on how it treats CBD and other extracts. The European Industrial Hemp Association (EIHA) sent an alert this week to roughly 300 members urging the EU to change its Common Agricultural Policy, which governs food... Read more
(Photo courtesy of Hemptown) (This is an abridged version of a story that appears in the July issue of Marijuana Business Magazine.) Traditionally, industrial hemp has two main commercial uses: food and fiber. The two uses have distinctly different storage needs: Food: Hemp grain storage is often kept on-farm. Canada... Read more
(Photo courtesy of Hemptown) (This is an abridged version of a story that appears in the July issue of Marijuana Business Magazine. On Wednesday, read about strategies for storing hemp fiber and grain.) Storing hemp properly is arguably as important as planting, harvesting or any other step in the cultivation... Read more
U.S. health authorities are taking final comments from the public on how to regulate over-the-counter cannabis extracts such as CBD. The suggestions are due to the U.S. Food and Drug Administration (FDA) by midnight ET Tuesday on how the agency should regulate cannabis-derived products. The FDA has vowed to expedite its... Read more
A Toronto-based hemp and CBD investment company increased its stake in a traditional soda company with an eye toward developing CBD-infused beverages with the brand. HeavenlyRx bought 15 million shares in Jones Soda Co. for $9 million and now holds 39% of the Seattle-based beverage manufacturer. The deal also gives HeavenlyRx two... Read more
As the hemp industry waits for the U.S. Department of Agriculture (USDA) to finish its federal hemp production rules in time for the 2020 season, hemp companies are speculating whether the agency will further define which varieties and cultivars will be allowed to be used under the 2018 Farm... Read more
Sol Global, a Toronto-based international cannabis investment firm, has increased its stake in a privately held CBD company. The firm announced Friday it spent $11.5 million (15 million Canadian dollars) in HeavenlyRx. The purchase brings Sol Global to a 42% stake in HeavenlyRx. The announcement comes less than a... Read more
Federal health regulators say they’ll update the hemp industry on their CBD review by late summer or fall. Dr. Amy Abernethy, who leads the U.S. Food and Drug Administration’s work group on cannabinoids such as CBD, said Friday the agency is “enthusiastic about research into the therapeutic benefits of CBD... Read more
California-based Demetrix secured $50 million in a Series A funding, which the company will use for research of synthetic cannabinoid production. The Emeryville company wants to use baker’s yeast to produce large volumes of cannabinoids. More than 100 of cannabinoids can be found in the cannabis plant, sometimes in... Read more
State regulators in South Dakota have devoted the summer of 2019 to learning about hemp following Gov. Kristi Noem’s veto of a measure that would have allowed for hemp production in 2019. South Dakota is one of the only western states has not passed legislation to enable hemp production... Read more
